A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
Clinical trial NCT06104553 · UNKNOWN
Trial details
- NCT number
- NCT06104553
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2025-12-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.